Abstract
Nanomedicine has emerged as a transformative field in the healthcare industry, particularly in the area of targeted drug delivery. Recent advancements in nanotechnology have enabled the development of novel drug delivery systems capable of improving the bioavailability, stability, and controlled release of therapeutic agents. These systems utilize nanoparticles to deliver drugs specifically to the targeted tissues, minimizing side effects and enhancing therapeutic efficacy. This article explores the latest breakthroughs in nanomedicine for targeted drug delivery systems, discussing the types of nanoparticles used, mechanisms of drug targeting, and the challenges faced in clinical applications. The article concludes by examining the future potential of nanomedicine in revolutionizing personalized treatment protocols.
All articles published in the American Journal of Pharmacy and Pharmacology are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows others to:
-
Share — copy and redistribute the material in any medium or format
-
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Under the following terms:
-
Attribution — Appropriate credit must be given to the original author(s) and source, a link to the license must be provided, and any changes made must be indicated.
By submitting their work, authors agree to these licensing terms and retain copyright of their articles.